Does Dr. RICHARD KONSTANCE have financial conflicts of interest?

Dr. RICHARD KONSTANCE (M.D.) has received a total of $6,618 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $6,618 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RICHARD KONSTANCE?

According to CMS Open Payments data, Dr. RICHARD KONSTANCE received funding from NOVARTIS PHARMACEUTICALS CORPORATION ($783), BOSTON SCIENTIFIC CORPORATION ($623), and MEDTRONIC ($601).

Does Dr. RICHARD KONSTANCE receive research grants or speaking fees?

Dr. RICHARD KONSTANCE has received $6,618 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RICHARD KONSTANCE

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Interventional Cardiology

Practice Location: ROANOKE, VA 24018

NPI Number: 1407893639

LIFETIME INDUSTRY VALUE

$6,618

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. KONSTANCE is a verified Internal Medicine, Interventional Cardiology practitioner based in ROANOKE, VA.

Between 2021 and 2024, Dr. KONSTANCE had an overall industry promotional and research financial footprint of $6,618 as recorded in the federal CMS Open Payments database.

$6,618 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. KONSTANCE's primary funding source is NOVARTIS PHARMACEUTICALS CORPORATION, which accounts for $783 (representing 11.8% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 1

$783

11.8%

BOSTON SCIENTIFIC CORPORATION

Rank 2

$623

9.4%

MEDTRONIC

Rank 3

$601

9.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.